Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
about
Genetic testing for prevention of severe drug-induced skin rashDrug induced exfoliative dermatitis: state of the artNew genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivityEvolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.The search for circulating epilepsy biomarkersDrug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current conceptsFever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.Phenytoin-induced toxic epidermal necrolysis: Review and recommendationsSevere Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical ImplementationThe Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityProgress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityGenetics and genomics in Thailand: challenges and opportunitiesHuman leucocyte antigen-adverse drug reaction associations: from a perspective of ethnicity.Pharmacogenomics of off-target adverse drug reactions.HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis.Stevens-Johnson Syndrome following Failure of Genetic Screening prior to Carbamazepine Prescription.Genotyping for severe drug hypersensitivity.HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective reviewPharmacogenetics of drug hypersensitivity.HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in EuropeansGenome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions.Clinical application of pharmacogenomics.Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosingRecommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.Human leukocyte antigen typing using a knowledge base coupled with a high-throughput oligonucleotide probe array analysis.Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.Drug hypersensitivity: pharmacogenetics and clinical syndromes.Epidemiology and risk factors for drug allergy.Pharmacogenomics--how close/far are we to practising individualized medicine for children?PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.Cytochrome P450-mediated bioactivation of the epidermal growth factor receptor inhibitor erlotinib to a reactive electrophileAssociation of HLA-B*1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis.Computer aided identification of sodium channel blockers in the clinical treatment of epilepsy using molecular docking tools.HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese.A case for pharmacogenomics in management of cardiac arrhythmias.PharmGKB summary: phenytoin pathway.Bibliometric analysis of literature on toxic epidermal necrolysis and Stevens-Johnson syndrome: 1940 - 2015
P2860
Q24202114-C1527AC9-95E5-45FE-B604-83D8FB46A785Q26739886-5E20457A-69AA-4CD6-9B71-22B72D27C259Q26800976-B6988F98-ED71-4B9F-BE6C-52D173F6D0C4Q26800980-B3E00859-32C2-49F3-A3E2-AAD0C3D30B53Q26851663-22AAF830-BA69-4C7B-A01A-F07CF6D0C063Q27030788-9C5FABEF-8D9D-41BB-9CC3-BA8E782877B1Q27692095-96064BF1-FCC8-4435-9BD3-FBB2DF630D68Q28074656-F66453BA-C9C5-40EE-823C-D9AC929EA24BQ28076600-3787C89E-07FD-4776-ADFE-11C832BE81CFQ28080256-CE858D9B-8A51-417F-AE51-CFCA7CECE354Q28083100-2F1F8872-811C-457B-A398-79F9F48C88A7Q28658627-D0A6653D-81E4-42E4-BD3B-21028802DA1EQ30238992-BA6107DA-8C77-4B4F-8679-C2841B3B479AQ30400366-98F04E30-AB07-455B-86C8-8A4187370826Q30855868-3F7DCF66-4E52-41B0-BEF1-ABDC10FEDBC0Q33572210-756152B3-8F72-465B-8172-345F0095F576Q33582530-8AEFCEEA-6FA1-43DC-B16E-934AC381021FQ33666857-1EAC9663-43D6-47C0-9AF5-D881BA8EDEC6Q34016198-F841D3FC-AE3F-4AF1-AFA8-1AC98C419817Q34118186-A5C1DA5F-2FC5-4443-867D-B056E6D46510Q34172669-8EB39682-B1F9-4E72-8E87-6E1ED68A383FQ34257932-44B1D914-F0FB-447F-8CF9-640AEBCAE807Q34280685-6192EDD2-8E13-4CB4-B40B-BBCF016E5B14Q34345953-DCFE459A-37E0-42F9-BC8A-C49A1F4CB1C5Q34389432-BA2D2FC5-11B5-4DBC-BC40-5BE1243524D3Q34408357-0ED55B9B-01E9-4A0E-85CB-51C80BB0C765Q34557668-B91A7CE8-2C3D-4362-A14D-E39C39CE42CBQ34579653-71B12AE7-A17B-41EE-978E-A20BB2A2ACDEQ34617803-B220F870-6D72-4D3A-B365-1DE9E095778FQ34701492-0B174CF1-5ECD-4EEF-8F09-37F9183D8E82Q34976470-75B2C2D4-F306-49DC-B253-E88E617CAA2AQ35135951-B3B603AC-38DF-4F1A-81A4-EF0D34414BFBQ35168561-5D45E629-CBB6-4085-B505-821ADCC145E4Q35453113-85D3247C-541C-49C1-A227-9E8BD6DD6DCBQ35453569-74863239-94B9-4AEA-8007-C573B9D21F33Q35483670-9D71619D-5E83-4569-9491-7695C4A902D3Q35555607-F7F2405A-6300-4E83-9943-DCDCF031DC66Q35914690-017EB181-ECF9-4270-A230-9E7BDF4FD752Q35950546-BD8698F3-BDF8-44CA-8BCB-94CA64792E18Q36253270-1FA47A35-7E1D-4595-9004-BC07B132C026
P2860
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Carbamazepine and phenytoin in ...... 502 allele in Thai population.
@ast
Carbamazepine and phenytoin in ...... 502 allele in Thai population.
@en
Carbamazepine and phenytoin in ...... 502 allele in Thai population.
@nl
type
label
Carbamazepine and phenytoin in ...... 502 allele in Thai population.
@ast
Carbamazepine and phenytoin in ...... 502 allele in Thai population.
@en
Carbamazepine and phenytoin in ...... 502 allele in Thai population.
@nl
prefLabel
Carbamazepine and phenytoin in ...... 502 allele in Thai population.
@ast
Carbamazepine and phenytoin in ...... 502 allele in Thai population.
@en
Carbamazepine and phenytoin in ...... 502 allele in Thai population.
@nl
P2093
P1433
P1476
Carbamazepine and phenytoin in ...... 1502 allele in Thai population
@en
P2093
Chaichon Locharernkul
Chusak Limotai
Jakrin Loplumlert
Kanya Suphapeetiporn
Nattiya Hirankarn
Oratai Kangwanshiratada
Siraprapa Tongkobpetch
Tayard Desudchit
Wiwat Korkij
P2860
P304
P356
10.1111/J.1528-1167.2008.01719.X
P577
2008-07-14T00:00:00Z